Banque de données en santé publique

Aide

Résultats de votre recherche

Votre recherche

mc.\*:("Amphotericin B")

Document Type [dt]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Année de publication [ap]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Résultats 1 à 21 sur 21

  • Page / 1

Export

Sélection :

  • et

Homophily and co-occurrence patterns shape randomized trials agendas : illustration in antifungal agents.RIZOS (Evangelos-C) ; SALANTI (Georgia) ; KONTOYIANNIS (Dimitrios-P) et al. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2011; 830-842, issn 0895-4356ARTICLE.

Editorial response : Choosing amphotericin B formulations : Between a rock and a hard place. BENNETT (John). CLINICAL INFECTIOUS DISEASES. 2000; 1164-1165, issn 1058-4838ARTICLE.

Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infections.KUTI (Joseph-L) ; KOTAPATI (Srividya) ; WILLIAMS (Peter) et al. PHARMACOECONOMICS. 2004; 301-310, issn 1170-7690ARTICLE.

Amphotericin B revisted : reassessment of toxicity.CLEMENTS (J.S.JR;) ; PEACOCK (J.E.JR.) ; Wake forest univ. Bowman gray school medicine. Sect infectious diseases. Winston Salem NC. USA. AMERICAN JOURNAL OF MEDICINE. 1990; 522N-527N, issn 0002-9343ARTICLE.

Current management of funguria. GUBBINS (P.O.) ; MCCONNELL (S.A.) ; PENZAK (S.R.) et al. AMERICAN JOURNAL OF HEALTH SYSTEM PHARMACY. 1999; 1929-1938, issn 1079-2082ARTICLE.

Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. BERMAN (J.D.) ; BADARO (R.) ; THAKUR (C.P.) et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION. 1998; 25-32, issn 0042-9686ARTICLE.

Mortality and costs of acute renal failure associated with amphotericin B therapy. BATES (D.W.) ; SU (L.) ; YU (D.T.) et al. CLINICAL INFECTIOUS DISEASES. 2001; 686-693, issn 1058-4838ARTICLE.

U.S. food and Drug administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Author's reply. MEYERHOFF (A.) ; BERMAN (J.D.). CLINICAL INFECTIOUS DISEASES. 1999; 42-51, issn 1058-4838ARTICLE.

Lipid formulations of amphotericin B : Clinical efficacy and toxicities. WONG-BERINGER (A.) ; JACOBS (R.A.) ; GUGLIELMO (B.J.) et al. CLINICAL INFECTIOUS DISEASES. 1998; 603-618, issn 1058-4838ARTICLE.

Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis. JOHANSEN (H.K.) ; GOTZSCHE (P.C.) ; The Nordic Cochrane Centre. Rigshospitalet. Copenhagen. DNK. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 1999; 1752-1759, issn 0098-7484ARTICLE.

Update on antifungal agents for paediatric patients. = Mise à jour sur les antifongiques pour les patients de pédiatrie.GROLL (A.H.) ; TRAGIANNIDIS (A.). CLINICAL MICROBIOLOGY AND INFECTION. 2010; 1343-1353, issn 1198-743XARTICLE.

Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan : serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility. = Caractéristiques microbiologiques d'isolats cliniques de Cryptococcus neoformans à Taïwan : sérotype, types moléculaires, facteurs de virulence et sensibilité aux antifongiques.LIAW (S.J.) ; WU (H.C.) ; HSUEH (P.R.). CLINICAL MICROBIOLOGY AND INFECTION. 2010; 696-703, issn 1198-743XARTICLE.

Épidémiologie de la cryptococcose neuroméningée à Bamako - Mali.OUMAR (A.A.) ; DAO (S.) ; POUDIOUGOU (B.) et al. MEDECINE D'AFRIQUE NOIRE. 2008; 309-312, issn 0465-4668ARTICLE.

Amphotéricine B liposomale en première intention dans la leishmaniose viscérale infantile en région Provence-Alpes-Côte-d'Azur-Corse. = First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France.MINODIER (P.) ; ROBERT (S.) ; NOEL (G.) et al. ARCHIVES DE PEDIATRIE. 2005; 1102-1108, issn 0929-693XARTICLE.

Histoplasmose africaine à Histoplasma capsulatum var. duboisii A propos d'un cas au Mali. = African histoplasmosis (Histoplasma capsulatum var. duboisii) : a case report from Mali.MINTA (Daouda-K) ; DEMBELE (Mamadou) ; LORRE (Gilbert) et al. SANTE. 2005; 195-199, issn 1157-5999ARTICLE.

High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients : epidemiology and antifungal susceptibility. = Incidence élevée de candidémies à Candida parapsilosis chez des patients de réanimation non neutropéniques : épidémiologie et résistance aux antifongiques.DIZBAY (M.) ; FIDAN (I.) ; KALKANCI (A.) et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2010; 114-120, issn 0036-5548ARTICLE.

Decontamination of the digestive tract and oropharynx in ICU patients. = Décontamination digestive et oropharyngée chez les patients en réanimation.DE SMET (A.M.) ; KLUYTMANS (J.A.) ; COOPER (B.S.) et al. THE NEW ENGLAND JOURNAL OF MEDICINE. 2009; 20-31, issn 0028-4793ARTICLE.

Environmental and clinical epidemiology of Aspergillus terreus : data from a prospective surveillance study. = Epidémiologie clinique et environnementale d'Aspergillus terreus : résultats d'une étude de surveillance prospective.RUPING (M.) ; GERLACH (S.) ; FISCHER (G.) et al. THE JOURNAL OF HOSPITAL INFECTION. 2011; 226-230, issn 0195-6701ARTICLE.

Treatment of Mediterranean visceral leishmaniasis.GRADONI (L.) ; BRYCESON (A.) ; DESJEUX (P.). BULLETIN OF THE WORLD HEALTH ORGANIZATION. 1995; 191-197, issn 0042-9686ARTICLE.

Heterogeneity in antifungal susceptibility of clones of Candida alblcans isolated on single and sequential visits from a HIV-infected southern Chinese cohort. SAMARANAYAKE (Y.H.) ; SAMARANAYAKE (L.P.) ; TSANG (P.C.) et al. JOURNAL OF ORAL PATHOLOGY AND MEDICINE. 2001; 336-346, issn 0904-2512ARTICLE.

AmBisome.BONE MARROW TRANSPLANTATION - SUPPLEMENT. 1994; 22p., issn 0951-3078FASCICULE, CONGRES.

  • Page / 1